Disability Reduction Is a Twist in Negative BTKi RRMS Trial
These data rule out the study hypothesis that a BTKi offers greater protection against relapse than a commonly used immunomodulator.
MDedge News
source https://www.medscape.com/s/viewarticle/disability-reduction-twist-negative-btki-rrms-trial-2024a1000hab?src=rss
MDedge News
source https://www.medscape.com/s/viewarticle/disability-reduction-twist-negative-btki-rrms-trial-2024a1000hab?src=rss
Comments
Post a Comment